CD226 and autoimmune disease: The results of our previous studies demonstrated that mice treated with an anti-CD226 pAb in vivo have markedly decreased EAE susceptibility (27), in agreement with recent data showing that CD226 is involved in the pathogenesis of autoimmune diseases (8, 9).